I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Shi, Yuankai
474
results:
Search for persons
X
Format
Online (474)
Mediatypes
Articles (Online) (286)
Bookchapter (Online) (10)
OpenAccess-fulltext (178)
Languages
english (385)
Sorted by: Relevance
Sorted by: Year
?
1
Long-term outcomes with HLX01 (HanliKang®), a rituximab bio..:
Qin, Yan
;
Song, Yongping
;
Wang, Dong
...
BMC Cancer. 24 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1186/..
?
2
High-Throughput Antigen Microarray Identifies Longitudinal ..:
Dai, Liyuan
;
Tan, Qiaoyun
;
Li, Lin
...
Molecular & Cellular Proteomics. 23 (2024) 5 - p. 100749 , 2024
Link:
https://doi.org/10.1016/..
?
3
Deciphering the Prognostic Significance of MYD88 and CD79B ..:
Xie, Zucheng
;
Qin, Yan
;
Chen, Xinrui
...
Targeted Oncology. 19 (2024) 3 - p. 383-400 , 2024
Link:
https://doi.org/10.1007/..
?
4
Efficacy and safety of anlotinib plus penpulimab as second-..:
Zhang, Changgong
;
Chen, Jianhua
;
Wu, Huijuan
...
Cancer Pathogenesis and Therapy. 2 (2024) 4 - p. 268-275 , 2024
Link:
https://doi.org/10.1016/..
?
5
Patient-reported outcomes for the phase 3 FURLONG study of ..:
Shi, Yuankai
;
Chen, Gongyan
;
Wang, Xiang
...
The Lancet Regional Health - Western Pacific. 48 (2024) - p. 101122 , 2024
Link:
https://doi.org/10.1016/..
?
6
Iruplinalkib (WX-0593) Versus Crizotinib in ALK TKI-Naive L..:
Shi, Yuankai
;
Chen, Jianhua
;
Yang, Runxiang
...
Journal of Thoracic Oncology. 19 (2024) 6 - p. 912-927 , 2024
Link:
https://doi.org/10.1016/..
?
7
The co‐location of CD14+APOE+ cells and MMP7+ tumour cells ..:
Fan, Guangyu
;
Xie, Tongji
;
Tang, Le
...
Clinical and Translational Medicine. 14 (2024) 9 - p. , 2024
Link:
https://doi.org/10.1002/..
?
8
Efficacy and safety of utidelone for the treatment of patie..:
Shi, Yuankai
;
Chen, Gongyan
;
Zhao, Yanqiu
..
Cancer Pathogenesis and Therapy. 2 (2024) 2 - p. 103-111 , 2024
Link:
https://doi.org/10.1016/..
?
9
Ficonalkib (SY-3505) in Advanced ALK-Positive NSCLC: A Mult..:
Shi, Yuankai
;
Hu, Xingsheng
;
Li, Xingya
...
Journal of Thoracic Oncology. 19 (2024) 6 - p. 898-911 , 2024
Link:
https://doi.org/10.1016/..
?
10
Single-cell and spatial analyses revealed the co-location o..:
Fan, Guangyu
;
Xie, Tongji
;
Li, Lin
...
npj Precision Oncology. 8 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1038/..
?
11
Single-cell and spatial transcriptomics reveal a high glyco..:
Dai, Liyuan
;
Fan, Guangyu
;
Xie, Tongji
...
Biomarker Research. 12 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1186/..
?
12
Plinabulin plus docetaxel versus docetaxel in patients with..:
Han, Baohui
;
Feinstein, Trevor
;
Shi, Yuankai
...
The Lancet Respiratory Medicine. , 2024
Link:
https://doi.org/10.1016/..
?
13
Mutational variant allele frequency profile as a biomarker ..:
Gao, Ruyun
;
Lou, Ning
;
Li, Lin
...
Journal of Translational Medicine. 22 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1186/..
?
14
Longitudinal plasma proteomic analysis identifies biomarker..:
Tan, Qiaoyun
;
Gao, Ruyun
;
Zhang, Xiaomei
...
Cancer Immunology, Immunotherapy. 73 (2024) 3 - p. , 2024
Link:
https://doi.org/10.1007/..
?
15
Tunlametinib (HL-085) plus vemurafenib in patients with adv..:
Shi, Yuankai
;
Han, Xiaohong
;
Zhao, Qian
...
Experimental Hematology & Oncology. 13 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1186/..
1-15